Board Meeting8 Aug 2026, 03:31 pm
Panacea Biotec Board Meeting on Aug 13 to Approve Q1 FY27 Results
AI Summary
Panacea Biotec Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. The company also informed that the trading window for designated persons will remain closed from July 1, 2026, until August 15, 2026, in compliance with SEBI regulations.
Key Highlights
- Board meeting scheduled for August 13, 2026.
- To approve standalone and consolidated unaudited financial results.
- Results pertain to the quarter ended June 30, 2026.
- Trading window closure extended until August 15, 2026.
Price Impact
More from PANACEABIO